International CML Foundation

You are here: Home

Welcome to the Website of the
International Chronic Myeloid Leukemia Foundation (iCMLf)

The iCMLf is a charitable foundation established by a group of hematologists with a strong interest in Chronic Myeloid Leukemia (CML). The mission of the iCMLf is to improve the outcomes for patients with CML globally. It aims to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML. Scientific advisors and national representatives spanning over 30 countries provide guidance and advice to further the aims of the iCMLf. Read more here.

ASH 2011: Summaries of the CML Education Session and Key CML Presentations

Like every year in December, about 21.000 hematologists and health professionals (as well as a small group of patient advocates) convened at the Annual Meeting of the American Society of Hematology (ASH) to hear latest news from clinical trials. The CML Advocates Network has attended the CML sessions and summarized the key presentations and posters on Nilotinib, Dasatinib, Bosutinib, Ponatinib, DCC-2036, Imatinib-Interferon combination, STOP studies, as well as some studies on CML and diabetes or fatigue, complemented by a patients' perspective. Read the summary of the CML Education Session and the summary of key highlights in the scientific sessions on CML.

Last Updated on Thursday, 22 December 2011 10:36 |

iCMLf Virtual Education Program: now also in Spanish and French

The '2011 edition' of the iCMLf Virtual Education Program was launched at ASH 2011. The eLearning program offers educational presentations by leading CML experts. The webcasts address practical aspects of the management of CML, e.g. first line treatment, managing resistance, treatment of advanced phase CML, molecular monitoring and mutation testing, bone marrow transplant, etc. All presentations target questions for physicians managing CML in emerging regions. The program was developed by the iCMLf in partnership with The Max Foundation. Check it out here.

Last Updated on Thursday, 15 December 2011 11:27 |

The Rowley Prize 2011 awarded to Prof. John Goldman

rowley-prize-2011_130px The winner of the Rowley Prize for 2011 is Prof. John Goldman, awarded at the start of the ESH-iCMLf meeting on 22. September 2012 in Estoril, Portugal. Dr Janet Rowley has kindly given the iCMLf permission to name this award in her honour. Read more about the Rowley Prize here.

Last Updated on Thursday, 20 October 2011 14:16 |

Patient groups and health professionals celebrate International CML Awareness Day, calling for joint action to improve patients access to diagnosis, treatment and care

cmlawday922_100px_trans 22 September 2011 is a very special date for patients affected by Chronic Myeloid Leukemia (CML), a rare blood cancer that has played a key role in the path towards personalized medicine in cancer. For the first time, patient advocacy groups from all continents will celebrate "International CML Awareness Day" on that date. Patient organisations of the CML Advocates Network from 49 countries, supported by The Max Foundation, Alianza Latina and the International CML Foundation, call on caregivers, healthcare professionals, government and industry to work together to improve on timely access to diagnosis, treatment and care.

iCMLf Forum 2011 at ASH: Physicians spotlight challenges of managing CML in emerging countries

During ASH 2011 in San Diego, the iCMLf in partnership with The Max Foundation has held its annual forum on "CML Management in Emerging Regions & Update of the Virtual Education Program". The event was attended by 90 physicians from emerging regions. It provided a valuable networking forum and panel discussion with iCMLf Directors including John Goldman, Jorge Cortes, Jerry Radich, Michele Baccarani, Andreas Hochhaus and Tim Hughes on the challenges and solutions for treating CML in emerging regions. The iCMLf also launched the 2011 update of its "Virtual Education Program", providing new CML educational modules in Spanish, French & English.

ERSAP Preceptorship Program: 2012 program is now open for applications

As the final two preceptors in 2011 leave from Brazil and the Ukraine traveling to the Hammersmith Hospital in London, the iCMLf is pleased to announce that the 2012 program is open for applications. The Emerging Regions Support and Partnership (ERSAP) Preceptorship Program is designed for clinicians from emerging economic regions with a specific interest in the treatment of CML and a significant CML patient load. The program enhances clinical knowledge and skills in the treatment of CML through preceptorships at internationally renowned CML centres. The ERSAP Preceptorship Program application form and overview brochure are available for download now. Alternatively contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it for further information.

iCMLf Annual Report 2011 available now!

The Annual Report 2011 of the iCMLf is now available! It features the Foundation's activities from 1 Sept 2011 to 31 August 2011, including the report from the Chairman as well as updates on the ERSAP programs, the Virtual Education Program, the Online Discussion Forum, the Sub-Saharan Africa Coalition, the International CML Awareness Day, the iCMLf-ESH meeting, the Rowley Prize 2011, the pediatric CML project, as well as iCMLf's mission, aims, objectives and finances. Download the report here: PDF, single A4 page (for printing), or PDF, double A4 page (for reading on widescreen displays)

Last Updated on Monday, 31 October 2011 08:54 |

The May 2011 issue of the iCMLf Newsletter is now available

Download the PDF file here - issues covered:

iCMLf Overview
ERSAP Preceptorship Program
CML in Nigeria
ILTE Study editorial
Virtual Education Program
iCMLf Online Discussion Forum
Pediatric CML Community
Diagnosis and Testing Program

Last Updated on Tuesday, 24 May 2011 11:29 |

More Articles...

Please donate

Welcome to the Website of theInternational Chronic Myeloid Leukemia Foundation (iCMLf)